These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Interaction of the effects of naloxone and oxymorphone on human respiration. Kallos T; Hudson HE; Rouge JC; Smith TC Anesthesiology; 1972 Mar; 36(3):278-85. PubMed ID: 5011421 [No Abstract] [Full Text] [Related]
83. Assessment of sedation after intranasal administration of midazolam and midazolam-butorphanol in cockatiels (Nymphicus hollandicus). Doss GA; Fink DM; Mans C Am J Vet Res; 2018 Dec; 79(12):1246-1252. PubMed ID: 30457900 [TBL] [Abstract][Full Text] [Related]
84. Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study. Kaplan JL; Marx JA Ann Emerg Med; 1993 Feb; 22(2):187-90. PubMed ID: 8427429 [TBL] [Abstract][Full Text] [Related]
85. Peripherally acting α-adrenoceptor antagonist MK-467 with intramuscular medetomidine and butorphanol in dogs: A prospective, randomised, clinical trial. Kallio-Kujala IJ; Turunen HA; Raekallio MR; Honkavaara JM; Salla KM; Casoni D; Hautajärvi HJ; Vainio OM Vet J; 2018 Oct; 240():22-26. PubMed ID: 30268328 [TBL] [Abstract][Full Text] [Related]
86. Yohimbine/flumazenil antagonism of hemodynamic alterations induced by a combination of midazolam, xylazine, and butorphanol in dogs. Gross ME; Tranquilli WJ; Thurmon JC; Benson GJ; Olson WA J Am Vet Med Assoc; 1992 Dec; 201(12):1887-90. PubMed ID: 1483907 [TBL] [Abstract][Full Text] [Related]
87. Naloxone reversal of ketobemidone induced respiratory, circulatory and narcotic effects in dogs. Aasen AO; Holst-Larsen H; Ormstad K; Rugstad HE Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():118-28. PubMed ID: 19923 [No Abstract] [Full Text] [Related]
88. Safety and efficacy of preoperative administration of meloxicam, compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgery. Mathews KA; Pettifer G; Foster R; McDonell W Am J Vet Res; 2001 Jun; 62(6):882-8. PubMed ID: 11400845 [TBL] [Abstract][Full Text] [Related]
89. Comparative study on the sedative effects of morphine, methadone, butorphanol or tramadol, in combination with acepromazine, in dogs. Monteiro ER; Junior AR; Assis HM; Campagnol D; Quitzan JG Vet Anaesth Analg; 2009 Jan; 36(1):25-33. PubMed ID: 19121156 [TBL] [Abstract][Full Text] [Related]
90. [Influence of four opioids on pulmonary oxygenation and naloxone's effects in mechanically ventilated dogs]. Takahashi H; Dohi S; Matsumiya N; Takeshima R; Naito H Masui; 1989 Jul; 38(7):880-7. PubMed ID: 2614900 [TBL] [Abstract][Full Text] [Related]
91. Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey. VanVugt DA; Webb MY; Reid RL Neuroendocrinology; 1989 Mar; 49(3):275-80. PubMed ID: 2716954 [TBL] [Abstract][Full Text] [Related]
92. The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects. Foldes FF; Duncalf D; Kuwabara S Can Anaesth Soc J; 1969 Mar; 16(2):151-61. PubMed ID: 5773493 [No Abstract] [Full Text] [Related]
93. Effect of medetomidine-butorphanol and dexmedetomidine-butorphanol combinations on intraocular pressure in healthy dogs. Rauser P; Pfeifr J; Proks P; Stehlík L Vet Anaesth Analg; 2012 May; 39(3):301-5. PubMed ID: 22420953 [TBL] [Abstract][Full Text] [Related]
94. Effects of midazolam-butorphanol, acepromazine-butorphanol and medetomidine on an induction dose of propofol and their compatibility in dogs. Sano T; Nishimura R; Mochizuki M; Sasaki N J Vet Med Sci; 2003 Oct; 65(10):1141-3. PubMed ID: 14600358 [TBL] [Abstract][Full Text] [Related]
95. Comparison of anesthetic and cardiorespiratory effects of tiletamine-zolazepam-butorphanol and tiletamine-zolazepam-butorphanol-medetomidine in dogs. Ko JC; Payton M; Weil AB; Kitao T; Haydon T Vet Ther; 2007; 8(2):113-26. PubMed ID: 17616946 [TBL] [Abstract][Full Text] [Related]
96. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine. Larson AA; Armstrong MJ Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013 [No Abstract] [Full Text] [Related]
97. Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection. Papich MG; Narayan RJ Drug Deliv Transl Res; 2022 Feb; 12(2):376-383. PubMed ID: 34817831 [TBL] [Abstract][Full Text] [Related]
98. Clinical pharmacology of antagonists of narcotic-induced respiratory depression. A brief review. Bowdle TA Acute Care; 1988; 12 Suppl 1():70-6. PubMed ID: 3278495 [TBL] [Abstract][Full Text] [Related]